228 related articles for article (PubMed ID: 31142270)
1. ERO1α is a novel endogenous marker of hypoxia in human cancer cell lines.
Takei N; Yoneda A; Kosaka M; Sakai-Sawada K; Tamura Y
BMC Cancer; 2019 May; 19(1):510. PubMed ID: 31142270
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-inducible ERO1α promotes cancer progression through modulation of integrin-β1 modification and signalling in HCT116 colorectal cancer cells.
Takei N; Yoneda A; Sakai-Sawada K; Kosaka M; Minomi K; Tamura Y
Sci Rep; 2017 Aug; 7(1):9389. PubMed ID: 28839225
[TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer.
Olive PL; Aquino-Parsons C; MacPhail SH; Liao SY; Raleigh JA; Lerman MI; Stanbridge EJ
Cancer Res; 2001 Dec; 61(24):8924-9. PubMed ID: 11751418
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia.
Tafreshi NK; Lloyd MC; Proemsey JB; Bui MM; Kim J; Gillies RJ; Morse DL
Mol Imaging Biol; 2016 Apr; 18(2):219-31. PubMed ID: 26276155
[TBL] [Abstract][Full Text] [Related]
5. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer.
Kaanders JH; Wijffels KI; Marres HA; Ljungkvist AS; Pop LA; van den Hoogen FJ; de Wilde PC; Bussink J; Raleigh JA; van der Kogel AJ
Cancer Res; 2002 Dec; 62(23):7066-74. PubMed ID: 12460928
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive molecular imaging of hypoxia in human xenografts: comparing hypoxia-induced gene expression with endogenous and exogenous hypoxia markers.
He F; Deng X; Wen B; Liu Y; Sun X; Xing L; Minami A; Huang Y; Chen Q; Zanzonico PB; Ling CC; Li GC
Cancer Res; 2008 Oct; 68(20):8597-606. PubMed ID: 18922936
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including acetazolamide in human glioblastoma.
Said HM; Hagemann C; Carta F; Katzer A; Polat B; Staab A; Scozzafava A; Anacker J; Vince GH; Flentje M; Supuran CT
Bioorg Med Chem; 2013 Jul; 21(13):3949-57. PubMed ID: 23706268
[TBL] [Abstract][Full Text] [Related]
8. Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo.
Said HM; Hagemann C; Staab A; Stojic J; Kühnel S; Vince GH; Flentje M; Roosen K; Vordermark D
Radiother Oncol; 2007 Jun; 83(3):398-405. PubMed ID: 17524506
[TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrase IX is a marker of hypoxia and correlates with higher Gleason scores and ISUP grading in prostate cancer.
Ambrosio MR; Di Serio C; Danza G; Rocca BJ; Ginori A; Prudovsky I; Marchionni N; Del Vecchio MT; Tarantini F
Diagn Pathol; 2016 May; 11(1):45. PubMed ID: 27225200
[TBL] [Abstract][Full Text] [Related]
10. Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix.
Jankovic B; Aquino-Parsons C; Raleigh JA; Stanbridge EJ; Durand RE; Banath JP; MacPhail SH; Olive PL
Cytometry B Clin Cytom; 2006 Mar; 70(2):45-55. PubMed ID: 16456867
[TBL] [Abstract][Full Text] [Related]
11. Modulation of carbonic anhydrase 9 (CA9) in human brain cancer.
Said HM; Supuran CT; Hageman C; Staab A; Polat B; Katzer A; Scozzafava A; Anacker J; Flentje M; Vordermark D
Curr Pharm Des; 2010; 16(29):3288-99. PubMed ID: 20819065
[TBL] [Abstract][Full Text] [Related]
12. Genetic disruption of the pHi-regulating proteins Na+/H+ exchanger 1 (SLC9A1) and carbonic anhydrase 9 severely reduces growth of colon cancer cells.
Parks SK; Cormerais Y; Durivault J; Pouyssegur J
Oncotarget; 2017 Feb; 8(6):10225-10237. PubMed ID: 28055960
[TBL] [Abstract][Full Text] [Related]
13. Expression of carbonic anhydrase 9 at the invasion front of gastric cancers.
Chen J; Röcken C; Hoffmann J; Krüger S; Lendeckel U; Rocco A; Pastorekova S; Malfertheiner P; Ebert MP
Gut; 2005 Jul; 54(7):920-7. PubMed ID: 15951534
[TBL] [Abstract][Full Text] [Related]
14. Expression of carbonic anhydrase 9, a potential intrinsic marker of hypoxia, is associated with poor prognosis in oesophageal squamous cell carcinoma.
Tanaka N; Kato H; Inose T; Kimura H; Faried A; Sohda M; Nakajima M; Fukai Y; Miyazaki T; Masuda N; Fukuchi M; Kuwano H
Br J Cancer; 2008 Nov; 99(9):1468-75. PubMed ID: 18841153
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the Prognostic Role of Carbonic Anhydrase 9 (CAIX) of the Cellular mRNA/Protein Level or Soluble CAIX Protein in Patients with Oral Squamous Cell Carcinoma.
Eckert AW; Horter S; Bethmann D; Kotrba J; Kaune T; Rot S; Bache M; Bilkenroth U; Reich W; Greither T; Wickenhauser C; Vordermark D; Taubert H; Kappler M
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30654595
[TBL] [Abstract][Full Text] [Related]
16. Expression of carbonic anhydrase IX is associated with poor prognosis through regulation of the epithelial‑mesenchymal transition in hepatocellular carcinoma.
Hyuga S; Wada H; Eguchi H; Otsuru T; Iwgami Y; Yamada D; Noda T; Asaoka T; Kawamoto K; Gotoh K; Takeda Y; Tanemura M; Umeshita K; Doki Y; Mori M
Int J Oncol; 2017 Oct; 51(4):1179-1190. PubMed ID: 28849188
[TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase 9 confers resistance to ferroptosis/apoptosis in malignant mesothelioma under hypoxia.
Li Z; Jiang L; Chew SH; Hirayama T; Sekido Y; Toyokuni S
Redox Biol; 2019 Sep; 26():101297. PubMed ID: 31442913
[TBL] [Abstract][Full Text] [Related]
18. Reduced expression of hypoxia-inducible factor-1alpha in perinecrotic regions of solid tumors.
Sobhanifar S; Aquino-Parsons C; Stanbridge EJ; Olive P
Cancer Res; 2005 Aug; 65(16):7259-66. PubMed ID: 16103077
[TBL] [Abstract][Full Text] [Related]
19. New Monoclonal Antibodies for a Selective Detection of Membrane-Associated and Soluble Forms of Carbonic Anhydrase IX in Human Cell Lines and Biological Samples.
Stravinskiene D; Imbrasaite A; Petrikaite V; Matulis D; Matuliene J; Zvirbliene A
Biomolecules; 2019 Jul; 9(8):. PubMed ID: 31349673
[TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnosis, prognosis and treatment.
Tostain J; Li G; Gentil-Perret A; Gigante M
Eur J Cancer; 2010 Dec; 46(18):3141-8. PubMed ID: 20709527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
